Cybuslky et al.32demonstrated that this drug significantly reduced the extent of atherosclerotic lesions in a murine model of accelerated atherosclerosis, with decreased VCAM‐1 expression. However, there is no available data regarding VCAM‐1 inhibition during MI and it might be of interest to study the effect of sVCAM‐1 inhibition in a preclinical model of MI. This evidence concerns the gene VCAM1 and atherosclerosis.